Safety and Efficacy of AGN201781 in Neuropathic Pain

This study will explore the safety and efficacy of AGN201781 in patients with postherpetic neuralgia or post-traumatic peripheral neuralgia

Inclusion Criteria:

• Diagnosis of postherpetic neuralgia or post-traumatic peripheral neuralgia
• Moderate or severe pain associated with postherpetic neuralgia or post-traumatic peripheral neuralgia

Exclusion Criteria:

• Women of child-bearing potential
• Any other uncontrolled diseases